INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
HM

Hahn Stephen M.

DirectorCIK 0002137706

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
HM
Hahn Stephen M.Director
FTHFaeth Therapeutics, Inc.
Derivative conversion
C—
44.8K sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Faeth Therapeutics, Inc.Director · Jun 16, 2026
9
HM
Hahn Stephen M.Director
FTHFaeth Therapeutics, Inc.
Grant or award
A
—
25.0K sh
Jun 12, 2026
Jun 16, 2026
traded Jun 12, 2026
+4d
SEC FORM 4

Evidence

9
HM
Hahn Stephen M.Director
FTHFaeth Therapeutics, Inc.
Derivative conversion
C—
45 sh
Jun 15, 2026Jun 16, 2026
traded Jun 15, 2026
+1dSEC FORM 4

Evidence